EP2448581A4
(en )
2013-02-20
Therapeutic compositions and related methods of use
EP2315780B8
(en )
2015-09-23
Compositions and methods of use for therapeutic antibodies
IL219974A0
(en )
2012-07-31
Therapeutic compounds and related methods of use
SG10201605794PA
(en )
2016-09-29
Stable Pharmaceutical Composition And Methods Of Using Same
IL218212A0
(en )
2012-04-30
Therapeutic methods and compositions
HRP20160902T1
(en )
2016-09-23
Compositions and methods of use of phorbolesters
EP2231665A4
(en )
2012-04-25
Novel compositions and methods of use
AU2010260585A8
(en )
2012-06-14
Compositions and methods for treatment of Multiple Sclerosis
EP2461870A4
(en )
2013-04-17
Therapeutic compositions and methods
WO2011130552A9
(en )
2012-02-02
Serca2 therapeutic compositions and methods of use
EP2381950A4
(en )
2012-08-22
Compositions and methods of use
HK1167143A
(en )
2012-11-23
Therapeutic compositions and related methods of use
HK1166236A
(en )
2012-10-26
Prebiotic formulations and methods of use
HK1177747A
(en )
2013-10-04
Hsa-related compositions and methods of use
AU2010901846A0
(en )
2010-05-20
Therapeutic methods and compositions
HK1169657A
(en )
2013-02-01
Diazahomoadamantane derivatives and methods of use thereof
AU2009905930A0
(en )
2009-12-24
Methods and Preparation and Uses of Xanthorrhoeaceae Compositions
AU2010902343A0
(en )
2010-06-17
Compositions for Therapy and Methods of Treatment
HK1176818A
(en )
2013-08-09
Amantadine compositions and methods of use
HK1172319A
(en )
2013-04-19
Therapeutic aryl-am i do-aryl compounds and their use
WO2009120815A9
(en )
2010-01-07
Therapeutic compositions and methods
AU2007900995A0
(en )
2007-03-15
Therapeutic Compositions and Methods of Treatment
HK1181643A
(en )
2013-11-15
Prebiotic formulations and methods of use
AU2008904468A0
(en )
2008-09-11
Vaccine composition and use of same
HK1166951A
(en )
2012-11-16
Compositions and methods of use for post-radiation protection